SEC Insider Transactions from Sibold William John.

Last updated: 2026-03-14 11:56 UTC | Total transactions: 19

Sibold William John, President and CEO of Madrigal Pharmaceuticals ($MDGL), sold about $9.2 million in company shares across six open market transactions over the past year. His most recent sale occurred on March 6, 2026. These sales rank him 1,203rd among over 11,000 insiders by total value sold, near the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases in this period.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
March 4, 2026 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO A Common Stock 14995 $0.00 163,492.0000 22,939,969 10.10% 0.07%
March 4, 2026 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO A Stock Option (Right to Buy) 18743 $0.00 18,743.0000 22,939,969 9999.99% 0.08%
March 6, 2026 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO S Common Stock 1663 $431.94 161,829.0000 22,939,969 1.02% 0.01%
Jan. 26, 2026 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO S Common Stock 1577 $492.42 148,497.0000 22,711,420 1.05% 0.01%
Dec. 4, 2025 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO S Common Stock 2400 $575.34 150,074.0000 22,711,420 1.57% 0.01%
Dec. 3, 2025 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO M Common Stock 50000 $0.00 152,474.0000 22,711,420 48.79% 0.22%
Dec. 3, 2025 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO M Performance Restricted Stock Units 50000 $0.00 0.0000 22,711,420 100.00% 0.22%
Sept. 9, 2025 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO S Common Stock 7279 $445.63 102,474.0000 22,080,246 6.63% 0.03%
Aug. 21, 2025 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO S Common Stock 6485 $400.03 110,884.0000 22,080,246 5.53% 0.03%
Aug. 21, 2025 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO S Common Stock 1131 $401.00 109,753.0000 22,080,246 1.02% 0.01%
March 5, 2025 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO A Common Stock 13066 $0.00 117,369.0000 22,080,246 12.53% 0.06%
March 5, 2025 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO A Stock Option (Right to Buy) 22009 $0.00 22,009.0000 22,080,246 9999.99% 0.10%
Feb. 27, 2025 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO M Performance Restricted Stock Units 50000 $0.00 0.0000 22,080,246 100.00% 0.23%
Feb. 27, 2025 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO M Common Stock 50000 $0.00 104,303.0000 22,080,246 92.08% 0.23%
Jan. 24, 2025 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO S Common Stock 1584 $335.24 54,303.0000 0 2.83% 0.00%
Sept. 9, 2024 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO S Common Stock 6363 $243.83 55,887.0000 0 10.22% 0.00%
Jan. 23, 2024 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO A Market Stock Unit 12250 $0.00 12,250.0000 0 9999.99% 0.00%
Jan. 23, 2024 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO A Common Stock 12250 $0.00 62,250.0000 0 24.50% 0.00%
Jan. 23, 2024 MADRIGAL PHARMACEUTICALS, INC. $MDGL Sibold William John President and CEO A Stock Option (Right to Buy) 18459 $0.00 18,459.0000 0 9999.99% 0.00%